Jedidiah Monson MD in Fresno, California

Home California Fresno

Jedidiah Monson MD has Radiation Oncology as his primary medical specialty. Their primary office is: 7130 N Millbrook Ave in Fresno, California.

They're a part of the: California Cancer Associates For Research And Excellence Inc medical group which has around 45 members. You can call their office at 559-326-1222 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Stanford University School Of Medicine and graduated in 1991 (around 33 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Jedidiah M Monson MD Office Phone and Directions

Jedidiah Monson MD
California Cancer Associates For Research And Excellence Inc
7130 N Millbrook Ave
Fresno, California 93720
559-326-1222

Patient Ratings
Please rate your experience with Jedidiah Monson MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 559-326-1222

Enter a starting address:

Healthcare Info for Jedidiah Monson MD

Medical School: Stanford University School Of Medicine
Graduation Year: 1991
The Primary Medical Specialty for Jedidiah Monson MD is listed as: Radiation Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 8729047261
NPI #: 1669455390
NPI Created On: 11/28/2005
NPI Last Updated Listed as: 05/03/2022
Primary Taxonomy Code: 2085R0001X
License Number:
G83275
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Ct scan guidance for insertion of radiation therapy fields
Management of radiation therapy, complex
Management of radiation therapy simulation, simple
Management of radiation therapy, simulation, complex
Management of radiation therapy, 3d
Calculation of radiation therapy dose
Management of modulation radiotherapy planning
Special radiation therapy planning
Radiation treatment devices, design and construction, complex
Radiation therapy consultation per week
Design and construction of device for radiation therapy
Radiation therapy consultation
Stereotactic body radiation therapy 1 or more lesions using imaging guidance
Radiation treatment management, 5 treatments
Stereotactic radiation treatment management of 1 or more lesions using imaging guidance, per treatment course
Special radiation treatment procedure
Psa (prostate specific antigen) measurement
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788540307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: ERLEADA

Name Of Drug #3: 59676-600-12

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788540309

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803163505

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407873

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $6

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407875

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $0

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407881

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407883

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $2

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407885

Being Disputed:: No

Product Related: No

Payments Total: $1

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407901

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $1

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783407903

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Radiation Oncology Professionals in Fresno

1.
Stephen Doggett MD

1340 W Herndon Ave
Fresno, CA
Minarets Medical Group, Inc.

2.
Ankit Agarwal

7014 N Whitney Ave
Fresno, CA
Bass Medical Group

3.
Steven Kurtzman MD

7887 N Cedar Ave
Fresno, CA
Cancer Therapy Medical Group Inc

4.
William Silveira

45 E River Park Pl W
Fresno, CA
Community Health Partners

5.
William Silveira

2823 Fresno St
Fresno, CA
Community Health Partners

6.
Nhat-long Pham

45 E River Park Pl W
Fresno, CA
Community Health Partners

Providers in California Cancer Associates For Research And Excellence Inc

1.Casandra Anderson Md

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Surgical Oncology

2.Amardeep Aulakh

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Internal Medicine

3.Pushpendu Banerjee Md

9850 Genesee Ave
La Jolla Ca 92037-1229
California Cancer Associates For Research And Excellence Inc
Medical Oncology

4.Pushpendu Banerjee Md

25405 Hancock Ave
Murrieta Ca 92562-5978
California Cancer Associates For Research And Excellence Inc
Medical Oncology

5.Pushpendu Banerjee Md

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Medical Oncology

6.Pushpendu Banerjee Md

838 Nordahl Rd
San Marcos Ca 92069-3599
California Cancer Associates For Research And Excellence Inc
Medical Oncology

View all 45 members of California Cancer Associates For Research And Excellence Inc medical group